ArticleJournal of thoracic disease2026
Prognostic significance of nodal skip metastasis in node-positive thoracic esophageal squamous cell carcinoma after esophagectomy.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prognostic significance of nodal skip metastasis (NSM) in esophageal cancer remains unclear. This study aimed to investigate the prognostic significance of NSM in patients with thoracic esophageal squamous cell carcinoma (T-ESCC) who had positive lymph nodes following esophagectomy and identify factors associated with its occurrence. Methods: A retrospective analysis was conducted on patients with T-ESCC who underwent esophagectomy between December 2020 and December 2024. Patients were classified into the NSM group and the non-nodal skip metastasis (NNSM) group based on postoperative lymph node patterns. Propensity score matching (PSM) was performed to account for baseline confounders and mitigate selection bias among patients. Risk factors for NSM were examined using Chi-squared test or Fisher exact test, followed by logistic binary regression. The influence of NSM on overall survival (OS) and disease-free survival (DFS) was evaluated using the Kaplan-Meier method and univariate and multivariate Cox proportional hazards models. Results: A total of 137 patients with T-ESCC were included, with an NSM incidence of 28.5%. Logistic regression analysis showed that N stage (P=0.003) was an independent risk factor for NSM. Patients in the NSM group had significantly higher 1-, 2-, and 3-year OS (P=0.041) and DFS (P=0.045) rates than those in the NNSM group. PSM produced 30 matched pairs, revealing no significant differences in OS (P=0.69) or DFS (P=0.65). Cox proportional hazards analyses indicated that N stage independently predicted OS (P=0.003) and DFS (P=0.001), whereas NSM was not an independent predictor of OS (P=0.39) and DFS (P=0.054). Conclusions: NSM was associated with more favorable survival in the unmatched cohort, but this association was not retained after PSM. These findings suggest that metastatic nodal burden, rather than the anatomical skip pattern itself, may play a more central role in postoperative prognosis among patients with node-positive T-ESCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.